EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential

Matic Munda, Tomaz Velnar

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2023.9518 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Matic Munda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Mesenchymal Stem Cell Transplantation, Intervertebral Disc, Low Back Pain. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem cell therapy has gained attention in the field of regenerative medicine due to its potential to restore damaged tissue. This article focuses on the application of stem cell therapy for treating spinal pathologies, particularly intervertebral disc degeneration. Disc degeneration is a major cause of low back pain and is characterized by changes in the matrix and inflammation. Animal studies have demonstrated that the implantation of mesenchymal stem cells (MSCs) yields promising results, including increased disc height, improved hydration, and reduced inflammation. However, the number of clinical trials remains limited, necessitating further research to optimize MSCs therapy. Although preclinical studies offer valuable insights, caution is needed when extrapolating these findings to clinical practice. Stem cell therapy still faces multiple challenges, such as the durability and survival of MSCs upon implantation, uncertain pathways to discogenic differentiation, and the adverse impact of a harsh microenvironment on cell survival. The avascular nature of the intervertebral disc and dynamic loading conditions also affect the adaptation of transplanted cells. Despite these obstacles, stem cell therapy holds promise as a potential treatment for disc degeneration, and ongoing research aims to fill the current gap in conclusive data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DegenerationMesenchymal Stem Cell TransplantationIntervertebral DiscLow Back PainAnimalsInflammation

Autor:innen und Institutionen

  • Department of Neurosurgery, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Department of Neurosurgery, University Medical Centre Ljubljana, Ljubljana, Slovenia; AMEU-AMC, Maribor, Slovenia.

Zitieren

APA

Munda, M., & Velnar, T. (2024). Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9518

Vancouver

Munda M, Velnar T. Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2023.9518

BibTeX
@article{Munda2024,
  author = {Munda, Matic and Velnar, Tomaz},
  title = {Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2023.9518}
}
Kostenlos starten →